This paper reports the synthesis and the binding assays on the 5-HT1A, 5-HT2A and 5-HT2C receptors of new norbornene and exo-N-Hydroxy-7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboximide derivatives in order to identify selective ligands for 5-HT1A subtype receptor. The combination of structural elements (heterocyclic nucleus, hydroxyl alkyl chain and 4-substituted piperazine) known to be critical for affinity to 5-HT1A receptors and the proper selection of substituents led to compounds with high specificity and affinity towards serotoninergic receptors. The more active compounds were selected and further evaluated for their binding affinities on D1 , D2 dopaminergic and α1, α2 adrenergic receptors. The 4-[3-[4-(2-furoyl)piperazin-1-yl]propoxy-2-ol]-4-aza-tricyclo [5.2.1.02,6]dec-8-ene-3,5-dione (3e) with Ki = 5.04 nM, was the most active and selective derivative for the 5-HT2C receptor with respect to other serotonin receptors and the most selective derivative vs. dopaminergic and adrenergic receptor.

Fiorino, F., Magli, E., Severino, B., Corvino, A., Ciano, A., Perissutti, E., et al. (2014). Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands. ARCHIV DER PHARMAZIE, 347(10), 698-706 [10.1002/ardp.201400174].

Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands

Massarelli, P.;Nencini, C.;
2014-01-01

Abstract

This paper reports the synthesis and the binding assays on the 5-HT1A, 5-HT2A and 5-HT2C receptors of new norbornene and exo-N-Hydroxy-7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboximide derivatives in order to identify selective ligands for 5-HT1A subtype receptor. The combination of structural elements (heterocyclic nucleus, hydroxyl alkyl chain and 4-substituted piperazine) known to be critical for affinity to 5-HT1A receptors and the proper selection of substituents led to compounds with high specificity and affinity towards serotoninergic receptors. The more active compounds were selected and further evaluated for their binding affinities on D1 , D2 dopaminergic and α1, α2 adrenergic receptors. The 4-[3-[4-(2-furoyl)piperazin-1-yl]propoxy-2-ol]-4-aza-tricyclo [5.2.1.02,6]dec-8-ene-3,5-dione (3e) with Ki = 5.04 nM, was the most active and selective derivative for the 5-HT2C receptor with respect to other serotonin receptors and the most selective derivative vs. dopaminergic and adrenergic receptor.
2014
Fiorino, F., Magli, E., Severino, B., Corvino, A., Ciano, A., Perissutti, E., et al. (2014). Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands. ARCHIV DER PHARMAZIE, 347(10), 698-706 [10.1002/ardp.201400174].
File in questo prodotto:
File Dimensione Formato  
ardp201400174.pdf

non disponibili

Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 752 kB
Formato Adobe PDF
752 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/840042
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo